Clinical, andrological and genetic characteristics of patients with congenital bilateral absence of vas deferens (CBAVD)

Archives of Andrology

Volumn 52, Issue 6, 2006, Pages 471-477

  Samli, Hale ^a   Samli, M M ^a   Yilmaz, E ^b   Imirzalioglu, N ^c,d  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d Cumhuriyet mah   (Turkey)

Author keywords

Congenital absence; Male infertility; Spermatogenesis; Vas deferens

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ALLELE; ANDROLOGY; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; CONGENITAL BILATERAL ABSENCE OF VAS DEFERENS; CYSTIC FIBROSIS; EPIDIDYMIS; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; PRIORITY JOURNAL; SEMINAL VESICLE; SPERMATOGENESIS; UROGENITAL TRACT MALFORMATION; VAS DEFERENS;

ABNORMALITIES, MULTIPLE; ADULT; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPIDIDYMIS; HUMANS; INFERTILITY, MALE; MALE; MIDDLE AGED; SEMINAL VESICLES; SPERM RETRIEVAL; SPERMATOGENESIS; VAS DEFERENS;

EID: 79961199191     PISSN: 01485016     EISSN: 15210375     Source Type: Journal    
DOI: 10.1080/01485010600691993     Document Type: Article

References (28)

1. Anguiano A, Oates RD, et al. (1992): Congenital bilateral absence of the vas deferens. JAMA 267:1794-1797.
2. Casal T, Bassas L, et al. (2000): Heterogenity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. Hum Reprod 15:1476-1483.
3. Chillon M, Casals T, et al. (1995): Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 332:1475-1480.
4. Chu CS, Trapnell BC, et al. (1992): Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J Clin Invest 90:785-790.
5. Claustres M (2005): Molecular pathology of the CFTR locus in male infertility. Reprod Biomed Online 10:14-41.
6. Cuppens H, Teng H, et al. (1994): CFTR haplotype backgrounds on normal and mutant CFTR genes. Hum Mol Genet 3:607-614.
7. Cuppens H, Cassiman JJ (2004): CFTR mutations and polymorphisms in male infertility. Int J Androl 27:251-256.
8. Daudin M, Bieth E, et al. (2000): Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counseling. Fertil Steril 74:1164-1174.
9. Dayangac D, Erdem H, et al. (2004): Mutations of the CFTR gene in Turkish patients with congenital bilateral absence of the vas deferens. Hum Reprod 19:1094-1100.
10. De Braekeleer M, Daigneault J, et al. (1996): Genealogy and geographical distribution of CFTR mutations in Saguenay Lac-Saint-Jean (Quebec, Canada). Ann Hum Biol 23:345-352.
11. Donat R, McNeill AS, et al. (1997): The incidence of cystic fibrosis gene mutations in patients with congenital bilateral absence of the vas deferens in Scotland. Br J Urol 79:74-77.
12. Dumur V, Gervais R, et al (1990): Abnormal distribution of CF delta F508 allele in azoospermic men with congenital aplasia of the epididymis and vas deferens. Lancet 336:512.
13. Hundrieser J, Bremer S, et al. (1990): Frequency of the F508 deletion in the CFTR gene in Turkish cystic fibrosis patients. Hum Genet 85:409-410.
14. Jarvi K, McCallum S, et al. (1998): Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutations. Fertil Steril 70:724-728.
15. Kanavakis E, Tzetis M, et al. (1998): Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligozoospermia. Mol Hum Reprod 4:333-337.
16. Kerem B, Rommens JM, et al. (1989): Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080.
17. Koprubasi FF, Malik N, et al. (1993): Molecular genetic analysis of Turkish cystic fibrosis patients. Ann Genet 36:144-149.
18. Marmar JL, Corson SL, et al. (1993): Microsurgical aspiration of sperm from the epididymis: a mobile program. J Urol 149:1368-1371.
19. Meng MV, Black LD, et al. (2001): Impaires spermatogenesis in men with congenital absence of the vas deferens. Hum Reprod 16:529-533.
20. Okada H, Iwamoto T, et al. (1996): Hyperprolactinemia among infertile patients and its effect on sperm functions. Andrologia 28:197-202.
21. Onay T, Topaloglu O, et al. (1998): Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I). Hum Genet 102:224-230.
22. Raman JD, Goldstein M (2004): The presence of vasal vessels in men with congenital bilateral absence of the vas deferens. J Urol 172:1941-1943.
23. Riordan JR, Rommens JM, et al. (1989): Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073.
24. Rommen JM, Iannuzzi MC, et al. (1989): Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059-1065.
25. Schlegel PN, Shin D, Goldstein M (1996): Urogenital anomalies in men with congenital absence of the vas deferens. J Urol 155(5):1644-1648.
26. Taille A, Rigot JM, et al. (1998): Correlation between genito-urinary anomalies, semen analysis and CFTR genotype in patients with congenital bilateral absence of the vas deferens. Br J Urol 81: 614-619.
27. Tchernitchko D, Legendre M, et al. (2003): Clinical evaluation of a reverse hybridization assay for the molecular detection of twelve MEFV gene mutations. Clin Chem 49:1781-1782.
28. Welsh MJ, Smith AE (1995): Cytic fibrosis. Sci Am 273:52-59.